ERBB2 and neoplasm: The LC3β status showed no significant association with age, gender, tumor location, tumor grade, tumor pathological stage, tumor nodal stage, tumor budding, tumor infiltrating lymphocytes, MMR status, and HER2 overexpression or patient survival.